Awareness of the Food and Drug Administration's Bad Ad Program and Education Regarding Pharmaceutical Advertising: A National Survey of Prescribers in Ambulatory Care Settings-Reference-Cited by-同舟云学术

Awareness of the Food and Drug Administration's Bad Ad Program and Education Regarding Pharmaceutical Advertising: A National Survey of Prescribers in Ambulatory Care Settings

Published:2015-07-15 Issue:11 Volume:20 Page:1330-1336
ISSN:1081-0730
Container-title:Journal of Health Communication
language:en
Short-container-title:Journal of Health Communication

Author:

O'Donoghue Amie C.,Boudewyns Vanessa,Aikin Kathryn J.,Geisen Emily,Betts Kevin R.,Southwell Brian G.

Publisher

Informa UK Limited

Subject

Library and Information Sciences,Public Health, Environmental and Occupational Health,Communication,Health (social science)

Link

http://www.tandfonline.com/doi/pdf/10.1080/10810730.2015.1018649

Reference23 articles.

1. American Association for Public Opinion Research. (2009).Standard definitions: Final dispositions of case codes and outcome rates for surveys. Retrieved from http://www.aapor.org/Content/NavigationMenu/ResourcesforResearchers/StandardDefinitions/StandardDefinitions2009new.pdf

2. Changing Interactions Between Physician Trainees and the Pharmaceutical Industry: A National Survey

3. Overconfidence among physicians and nurses: The ‘micro-certainty, macro-uncertainty’ phenomenon

4. The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities

5. Hemodynamic Assessment in Managing the Critically III

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physician interpretation of information about prescription drugs in scientific publications vs. promotional pieces;Research in Social and Administrative Pharmacy;2024-04

2. Defining and Measuring Scientific Misinformation;The ANNALS of the American Academy of Political and Social Science;2022-03

3. What influences healthcare providers’ prescribing decisions? Results from a national survey;Research in Social and Administrative Pharmacy;2021-10

4. Detecting and Reporting Deceptive Prescription Drug Promotion: Differences Across Consumer and Physician Audiences and by Number and Type of Deceptive Claims and Tactics;Health Communication;2021-04-12

5. A follow-up study on the effects of an educational intervention against pharmaceutical promotion;PLOS ONE;2020-10-28